Holcim cements Lafarge deal

published 10 April 2014

The world's two biggest cement makers are joining forces. Holcim of Switzerland is set to take over France's Lafarge, offering one of its shares for one Lafarge share and creating a group with combined sales of €39bn.

The new behemoth, which will be domiciled in Switzerland, expects to spend €1bn on the deal and hopes to achieve annual savings of €1.4bn by 2017.

What the commentators said

It's a highly concentrated sector, with just six firms comprising 40% of the global market outside China, and governments buy lots of cement, so they "want to know they are not being diddled". No wonder UBS thinks regulators could take two years to look at this deal.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

The firms have offered to sell assets accounting for 10%-15% of sales. These could go to rivals in Europe, giving them a boost, said Lex in the FT. But with 15 regulators in the mix, more sales may be needed, which could end up scuppering a deal.

Still, as Glencore/Xstrata showed, "where there's a will to get a deal done, there's usually a way to buy the watchdogs off, figuratively if not literally", said James Moore in The Independent. And the pair need to join forces.

They have too much capacity because growth from emerging markets hasn't (so far) come through, and both took on a great deal of debt in the go-go years, which has hit profitability.

But another worry for investors should be the deal's structure. Mergers of equals' tend to be "hastily bolted together" with the main jobs assigned for political reasons and not based on merit. They are "rarely satisfactory and never truly equal".

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.